Urinary transforming growth factor-β1 and α1-microglobulin in children and adolescents with type 1 diabetes

被引:37
作者
Korpinen, E
Teppo, AM
Hukkanen, L
Åkerblom, HK
Grönhagen-Riska, C
Vaarala, O
机构
[1] Univ Helsinki, Hosp Children & Adolescents, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Dept Med, Div Nephrol, FIN-00029 Helsinki, Finland
[3] Natl Publ Hlth Inst, Dept Biochem, Helsinki, Finland
关键词
D O I
10.2337/diacare.23.5.664
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- Transforming growth factor (TGF)-beta 1 is an important mediator in the pathogenesis of diabetic nephropathy. Urinary TGF-beta 1 reflects TGF-beta 1 production in the kidney, and alpha 1-microglobulin tubular dysfunction. These 2 markers were studied in the early phases of type 1 diabetes. RESEARCH DESIGN AND METHODS - There were 113 type 1 diabetic children and adolescents (mean +/- SD: age 14.1 +/- 2.9 years, and diabetes duration 7.4 +/- 2.9 years, HbA(1c) 9.3 +/- 1.5%) and 39 healthy subjects (age 13.8 +/- 2.8 years) who participated in the study. Of the diabetic patients, 105 were normoalbuminuric (2-3 consecutive overnight urinary albumin excretion rates [AERs] <20 mu g/min) and 8 had microalbuminuria (at least 2 AERs 20-200 mu g/min). Overnight urinary TGF-beta 1 and alpha 1-microglobulin levels were measured and the results expressed as the ratio to urinary creatinine concentration. RESULTS - Data are medians (range). Diabetic patients had higher urinary TGF-beta 1 levels than those of control subjects: 0.9 ng/mg (0.05-122.3) vs. 0.3 ng/mg (0.05-2.2) creatinine, respectively (P = 0.003). Urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.2, P = 0.03) and alpha 1-microglobulin (r = 0.2, P = 0.02) levels, but not with HbA(1c), AER, age, or duration of diabetes. In 43 patients with urinary TGF-beta 1 above the control levels, urinary TGF-beta 1 levels correlated with urinary glucose (r = 0.6, P ( 0.001) and alpha 1-microglobulin (r = 0.6, P < 0.001) levels. Diabetic patients had higher urinary alpha 1-microglobulin levels than those of control subjects: 4.8 mu g/mg (0.6-48.8) vs. 2.7 mu g/mg (0.8-11.6) creatinine, respectively (P < 0.001). alpha 1-Microglobulin levels correlated with AER (r = 0.2, P = 0.02), HbA(1c) (r = 0.3, P = 0.001), urinary glucose (r = 0.5, P < 0.001), and urinary TGF-beta 1 levels. CONCLUSIONS - An early rise in urinary TGF-P 1 levels was observed in young type 1 diabetic patients. Urinary TGF-beta 1 is associated with 2 interrelated tubular markers, alpha 1-microglobulin and urinary glucose.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 29 条
  • [1] Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM
    Berg, UB
    Torbjörnsdotter, TB
    Jaremko, G
    Thalme, B
    [J]. DIABETOLOGIA, 1998, 41 (09) : 1047 - 1056
  • [2] CYTOKINES IN KIDNEY-DISEASE - THE ROLE OF TRANSFORMING GROWTH-FACTOR-BETA
    BORDER, WA
    NOBLE, NA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (01) : 105 - 113
  • [3] Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents
    Bouhanick, B
    Gallois, Y
    Hadjadj, S
    de Casson, FB
    Limal, JM
    Marre, M
    [J]. DIABETES CARE, 1999, 22 (04) : 618 - 622
  • [4] TUBULAR DYSFUNCTION AND MICROALBUMINURIA IN INSULIN DEPENDENT DIABETES
    CHIARELLI, F
    LAPENNA, G
    MORGESE, G
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1989, 64 (04) : 635 - 635
  • [5] Urinary transforming growth factor-β (TGF-β) excretion and renal production of TGF-β in rats with subtotal renal ablation:: Effect of enalapril and nifedipine
    de Freitas, ASM
    Coimbra, TM
    Costa, RS
    Baroni, EA
    [J]. NEPHRON, 1998, 78 (03): : 302 - 309
  • [6] DiPaolo S, 1996, AM J PATHOL, V149, P2095
  • [7] Ellis D, 1998, CLIN CHEM, V44, P950
  • [8] FAGERUDD JA, 1997, KIDNEY INT S63, V52, P195
  • [9] Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes -: Effects of ACE inhibition
    Gilbert, RE
    Cox, A
    Wu, LL
    Allen, TJ
    Hulthen, UL
    Jerums, G
    Cooper, ME
    [J]. DIABETES, 1998, 47 (03) : 414 - 422
  • [10] Genetic control of the circulating concentration of transforming growth factor type β1
    Grainger, DJ
    Heathcote, K
    Chiano, M
    Snieder, H
    Kemp, PR
    Metcalfe, JC
    Carter, ND
    Spector, TD
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (01) : 93 - 97